Literature DB >> 31294779

Imaging Features Associated With Failure of Nonoperative Management of Intraabdominal Abscesses in Crohn Disease.

Daniel Perl1, Akbar K Waljee2,3,4, Shrinivas Bishu3, Peter D R Higgins3, Ashish P Wasnik5, Ryan W Stidham3,4.   

Abstract

BACKGROUND: Intraabdominal abscess management decisions in the treatment of Crohn disease (CD) can be challenging. Our aim was to determine the effect of clinical, medication use, and imaging disease characteristics on the need for future surgical management.
METHODS: A retrospective chart review was performed in patients with CD hospitalized for abscess confirmed by imaging between 2008 and 2016. Selection criteria included nonoperative management with intravenous antibiotics at the index hospitalization and a minimum of 2 years of follow up. Demographic, disease, and medication history were extracted from electronic medical records. Radiographic disease features were assessed by an expert abdominal radiologist, blinded to clinical data. The primary outcome was resection of the bowel segment involving the abscess within 2 years of index hospitalization. Cox proportional hazards regression and statistical methods were performed using SAS 9.4.
RESULTS: Of the 121 patients meeting the selection criteria, 36.4% avoided surgery after 2 years of follow up. On adjusted multivariable analysis, disease-activity factors including bowel wall thickness (HR 3.08, 95% CL 1.20-6.21), disease length (HR 2.67, 95% CL 1.40-6.20), bowel dilation (HR 2.19, 95% CL 1.02-4.68), and abscess size of greater than 6 cm (HR 2.47, 95%CL 1.17-5.21) were independent risk factors for future surgery in patients not undergoing immediate bowel resection for abscess management. Biologic use and percutaneous drainage were not risk factors for ultimate surgical management.
CONCLUSIONS: Radiographic CD features and abscess size over 6 cm are predictors of ultimately requiring bowel resection. Radiographic measures may help stratify patients to immediate surgery or conservative management for intraabdominal CD-related abscesses.
© 2019 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CT enterography; Crohn disease; IBD phenotype; MR enterography; abscess; fibrosis; imaging, decision support; inflammatory bowel disease; predictive modeling

Mesh:

Substances:

Year:  2019        PMID: 31294779      PMCID: PMC6855277          DOI: 10.1093/ibd/izz069

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  15 in total

1.  Percutaneous abscess drainage in Crohn disease: technical success and short- and long-term outcomes during 14 years.

Authors:  Debra A Gervais; Peter F Hahn; Mary J O'Neill; Peter R Mueller
Journal:  Radiology       Date:  2002-03       Impact factor: 11.105

2.  Efficacy of different therapeutic options for spontaneous abdominal abscesses in Crohn's disease: are antibiotics enough?

Authors:  Fernando Bermejo; Elena Garrido; María Chaparro; Jordi Gordillo; Miriam Mañosa; Alicia Algaba; Antonio López-Sanromán; Javier P Gisbert; Esther García-Planella; Iván Guerra; Eugeni Domènech
Journal:  Inflamm Bowel Dis       Date:  2011-08-29       Impact factor: 5.325

3.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.

Authors:  A Dignass; G Van Assche; J O Lindsay; M Lémann; J Söderholm; J F Colombel; S Danese; A D'Hoore; M Gassull; F Gomollón; D W Hommes; P Michetti; C O'Morain; T Oresland; A Windsor; E F Stange; S P L Travis
Journal:  J Crohns Colitis       Date:  2010-01-15       Impact factor: 9.071

4.  Effect of systemic corticosteroid therapy on risk for intra-abdominal or pelvic abscess in non-operated Crohn's disease.

Authors:  Anurag Agrawal; Shireen Durrani; Keith Leiper; Anthony Ellis; Anthony I Morris; Jonathan M Rhodes
Journal:  Clin Gastroenterol Hepatol       Date:  2005-12       Impact factor: 11.382

Review 5.  Crohn's disease complicated by strictures: a systematic review.

Authors:  Florian Rieder; Ellen M Zimmermann; Feza H Remzi; William J Sandborn
Journal:  Gut       Date:  2013-04-26       Impact factor: 23.059

6.  Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging.

Authors:  Jordi Rimola; Núria Planell; Sonia Rodríguez; Salvadora Delgado; Ingrid Ordás; Anna Ramírez-Morros; Carmen Ayuso; Montse Aceituno; Elena Ricart; Aranzazu Jauregui-Amezaga; Julián Panés; Míriam Cuatrecasas
Journal:  Am J Gastroenterol       Date:  2015-01-27       Impact factor: 10.864

7.  Similar outcomes of surgical and medical treatment of intra-abdominal abscesses in patients with Crohn's disease.

Authors:  Douglas L Nguyen; William J Sandborn; Edward V Loftus; David W Larson; Joel G Fletcher; Brenda Becker; Jay Mandrekar; William S Harmsen; David H Bruining
Journal:  Clin Gastroenterol Hepatol       Date:  2011-12-07       Impact factor: 11.382

8.  Management of intra-abdominal abscesses in children with Crohn's disease: a 12-year, retrospective single-center review.

Authors:  Jennifer L Dotson; Hillary Bashaw; Benedict Nwomeh; Wallace V Crandall
Journal:  Inflamm Bowel Dis       Date:  2015-05       Impact factor: 5.325

9.  Management of Crohn's disease in adults.

Authors:  Gary R Lichtenstein; Stephen B Hanauer; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2009-01-06       Impact factor: 10.864

10.  Outcome of medical treatment of stricturing and penetrating Crohn's disease: a retrospective study.

Authors:  Roxana Samimi; Mark H Flasar; Stephen Kavic; Kathleen Tracy; Raymond K Cross
Journal:  Inflamm Bowel Dis       Date:  2010-07       Impact factor: 5.325

View more
  1 in total

1.  Early Anti-Tumor-Necrosis-Factor Therapy for Crohn's Disease-Related Abdominal Abscesses and Phlegmon in Children.

Authors:  Brad D Constant; Edwin F de Zoeten; Jason P Weinman; Lindsey Albenberg; Frank I Scott
Journal:  Dig Dis Sci       Date:  2022-07-05       Impact factor: 3.487

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.